Page last updated: 2024-08-23

1-deoxynojirimycin and Cardiomyopathies

1-deoxynojirimycin has been researched along with Cardiomyopathies in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Duan, W; Jiang, L; Li, XY; Liu, J; Lu, L; Shi, H; Wang, X; Yang, J; Yu, S; Zhai, M; Zhang, L; Zhu, H1

Other Studies

1 other study(ies) available for 1-deoxynojirimycin and Cardiomyopathies

ArticleYear
1-Deoxynojirimycin attenuates septic cardiomyopathy by regulating oxidative stress, apoptosis, and inflammation via the JAK2/STAT6 signaling pathway.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2022, Volume: 155

    Topics: 1-Deoxynojirimycin; Animals; Antiviral Agents; Apoptosis; Cardiomyopathies; Cytokines; Heart Diseases; Hypoglycemic Agents; Inflammation; Janus Kinase 2; Janus Kinases; Lipopolysaccharides; Mice; Oxidative Stress; Reactive Oxygen Species; Sepsis; Signal Transduction

2022